HomeBALAXI • NSE
add
Balaxi Pharmaceuticals Ltd
Previous close
₹81.96
Day range
₹79.60 - ₹84.19
Year range
₹74.00 - ₹151.45
Market cap
4.35B INR
Avg Volume
39.08K
P/E ratio
14.05
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 773.82M | 41.41% |
Operating expense | 230.88M | 48.98% |
Net income | 45.89M | -68.19% |
Net profit margin | 5.93 | -77.51% |
Earnings per share | — | — |
EBITDA | 106.03M | 0.25% |
Effective tax rate | 17.50% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 608.67M | 116.28% |
Total assets | 2.88B | 34.27% |
Total liabilities | 720.97M | 22.20% |
Total equity | 2.16B | — |
Shares outstanding | 54.64M | — |
Price to book | 2.07 | — |
Return on assets | — | — |
Return on capital | 10.80% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 45.89M | -68.19% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1942
Website
Employees
600
